Based on published data, we hypothesized that blocking activation of STING could decrease retinal inflammatory cytokines, which in turn would inhibit diabetes-induced endothelial cell senescence and damage to the retinal vasculature. The gene discussed is STING1; the disease is diabetes mellitus.